Delivery Order SPE2DB20D1100-SPE2DB25FE1EV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,273.70 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of August 20, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,137.63 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication. This non-set-aside, competitively awarded contract was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and operates under a firm fixed price arrangement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $1,022.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 198 mg, a testosterone replacement therapy medication. The contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This IDC, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,347.66 for Jatenzo 198 mg capsules (120-count units) with a completion date of September 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $1,131.87 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This competitively awarded, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.92 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 158 mg on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price, competitively awarded contract represents a small-value pharmaceutical delivery with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency has awarded a delivery order valued at $1,697.81 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This is a firm fixed-price, non-set-aside contract awarded on September 25, 2025, with completion expected by September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,532.10 by the Defense Logistics Agency on June 6, 2025, with an ultimate completion date of June 9, 2025. The contract covers the supply of Jatenzo 198 mg capsules (120-count package), a testosterone replacement therapy medication. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The award is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,877.30 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $3,988.39 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1EVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,131.88 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 198 mg, a testosterone replacement medication. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive prime vendor contract enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The contract supports various federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/25/25 |